Furosemide Management in Acute Fluid Overload and Cirrhotic Ascites
Initiation of Therapy in Cirrhosis‑Related Ascites
- For a first episode of moderate (grade 2) ascites, begin spironolactone at 100 mg daily and increase by 100 mg every 72 hours up to a maximum of 400 mg daily. 2
- Add furosemide at 40 mg daily (titrating in 40‑mg increments to a maximum of 160 mg daily) only when spironolactone alone yields less than ≈ 2 kg weight loss per week or when hyper‑kalemia develops. 2
- In patients with long‑standing or recurrent ascites, start combination therapy (spironolactone + furosemide) from the outset and titrate both agents sequentially. 2
- For severe (grade 3) ascites, perform large‑volume paracentesis as the primary treatment; diuretics are used only as adjuncts. 2
Contra‑indications and Safety Thresholds in Cirrhosis
| Situation | Recommended Action | |
|---|---|---|
| Severe hyponatraemia (serum Na⁺ < 120–125 mmol/L) | Temporarily discontinue diuretics. | |
| Severe hypokalaemia (serum K⁺ < 3 mmol/L) | Stop furosemide until potassium is corrected. | |
| Severe hyperkalaemia (serum K⁺ > 6 mmol/L) | Hold spironolactone (furosemide may be continued). | |
| Acute kidney injury with oliguria and creatinine > 3 mg/dL | Withhold diuretics pending nephrology review. | |
| Worsening hepatic encephalopathy or incapacitating muscle cramps | Discontinue diuretics temporarily. | [2] |
- Prior to initiating any diuretic regimen in cirrhosis, correct active gastrointestinal bleeding, renal dysfunction, hepatic encephalopathy, and electrolyte abnormalities. 2
- Targeted fluid loss while on diuretics is ≈ 0.5 kg/day in patients without peripheral edema and ≈ 1 kg/day in those with edema. 2
- Diuretics are generally avoided in patients with persistent overt hepatic encephalopathy. 2
Initial Intravenous Dosing for Acute Fluid Overload (Non‑cirrhotic)
- Diuretic‑naïve patients: give a 20–40 mg IV bolus over 1–2 minutes. 1
- Patients already on chronic oral furosemide: administer at least twice the total daily oral dose intravenously (e.g., 40 mg PO → ≥ 80 mg IV). 1
- Severe volume overload: an initial IV bolus of 40–120 mg may be used. 1
Dose‑Escalation Limits
- Total IV furosemide ≤ 100 mg in the first 6 hours. 1
- Total IV furosemide ≤ 240 mg in the first 24 hours. 1
- Maximum daily dose ≈ 600 mg (up to 620 mg in continuous‑infusion protocols). 1
Monitoring and Early Indicators of Adequate Response
- Every 1–4 hours: record urine output (hourly preferred), vital signs (especially blood pressure), and clinical congestion (jugular venous pressure, lung crackles, peripheral edema). 1
- Daily: measure body weight at a consistent time, review intake‑output charts, and obtain serum electrolytes (K⁺, Na⁺, Mg²⁺) and renal function tests (creatinine, BUN). 1
- Predictors of successful diuresis: a spot urine sodium ≥ 50–70 mmol/L measured ~2 hours after the first dose, and urine output ≥ 0.5 mL/kg/h, both correlate with effective natriuresis. 1
When Not to Discontinue Furosemide During Decongestion
- A mild rise in serum creatinine (< 30 % from baseline) that occurs while achieving decongestion does not mandate stopping the diuretic. 1
- Hyponatraemia around 130 mmol/L in severe heart failure reflects disease severity rather than volume depletion; diuretic intensity should be increased, not withheld. 1
- Systolic blood pressure < 90 mmHg predicts a poorer diuretic response but is not an absolute contraindication; consider inotropic or vasopressor support while continuing furosemide. [1][3]
Discharge Planning and Outpatient Maintenance
- Ensure complete resolution of clinical congestion (normal jugular venous pressure, no peripheral edema, no lung crackles) before discharge, as residual congestion is linked to higher readmission and mortality. 1
- Typical oral maintenance dosing ranges from 20–80 mg once or twice daily, with an overall ceiling of 600 mg per day. 1
- Re‑check electrolytes and creatinine within 1–3 days for patients with advanced heart failure and within 7 days for all others. 1